key: cord-0829018-9xyrn0vq
authors: Pušnik, Jernej; Richter, Enrico; Schulte, Bianca; Dolscheid-Pommerich, Ramona; Bode, Christian; Putensen, Christian; Hartmann, Gunther; Alter, Galit; Streeck, Hendrik
title: Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help
date: 2021-06-11
journal: Cell Rep
DOI: 10.1016/j.celrep.2021.109320
sha: 6df123948a976e2dd9e185320af7a9af7583b110
doc_id: 829018
cord_uid: 9xyrn0vq

Memory B cells seem to be more durable than antibodies and thus crucial for the long-term immunity against SARS-CoV-2 infection. Here we investigate SARS-CoV-2 spike-specific memory B cells and their dependence on CD4+ T cell help in different settings of COVID-19. Compared to severely ill, individuals who recovered from mild COVID-19 develop fewer but functionally superior spike-specific memory B cells. Generation and affinity maturation of these cells is best associated with IL-21+CD4+ T cells in recovered individuals and CD40L+CD4+ T cells in severely ill individuals. The increased activation and exhaustion of memory B cells observed during COVID-19 correlates with CD4+ T cell functions. Intriguingly, CD4+ T cells recognizing membrane protein show a stronger association with spike-specific memory B cells than those recognizing spike or nucleocapsid proteins. Overall, we have identified CD4+ T cell subsets associated with the generation of B cell memory during SARS-CoV-2 infection.

With as of today over 103 million infected individuals worldwide and over 2 Million 35 deaths the SARS-CoV2 pandemic is an unprecedented public health emergency ((WHO), 36 2020). Despite the immense efforts and engagement of many research institutions 37 worldwide, to date, there is no available vaccine or treatment with proven efficacy against 38 SARS-CoV-2. Furthermore, there is an increasing concern that similar to other coronavirus 39

infections, infection with SARS-CoV-2 does not lead to a formation of long-lived 40 immunological memory (Huang et al., 2020, Kellam and Barclay, 2020) . For endemic 41

coronaviruses, it has been demonstrated that antibody levels substantially decrease six 42 months after the infection and that reinfections frequently occur 12-36 months following 43 the initial challenge. However, usually, existing partial immunity protects from a more severe 44 course after reinfection (Kissler et al., 2020 , Edridge et al., 2020 . These data indicate that 45 natural infection but also potentially vaccination can provide only short-period protection 46

against reinfection with SARS-CoV-2. Indeed, recent studies have suggested a rapid decline 47 of virus-specific antibody titers in recovered individuals and a slower decay after the initial 48 contraction phase (Seow et al., 2020 , Ibarrondo et al., 2020 , Wu et al., 2021 . However, 49

while antibody levels may decay, memory B and T cells, as well as plasmablasts, are often 50 maintained following viral infections. Memory B cells specific for the SARS-CoV-2 spike 51 protein were detected in recovered individuals and associated with neutralization of the 52 virus indicating their protective value (Kreer et al., 2020 , Juno et al., 2020 , Vaisman-Mentesh 53 et al., 25.08.2020 . A recent study demonstrated that, unlike antibodies, levels of spike-54 specific memory B cells remain stable during the first five months after the infection 55 (Vaisman-Mentesh et al., 25.08.2020) . If these findings can be extrapolated to a longer 56 period memory B cells might confer long-lived immunity against SARS-CoV-2. It is therefore 57 of great importance to elucidate the factors underlying the formation of robust memory B 58 cell response against SARS- It is well established that for the production of high-affinity antibodies capable of 60 binding protein antigens, B cells require helper signals from cognate CD4+ T cells. The 61

presence of virus-specific fully functional CD4+ T cells could therefore be a decisive factor for 62 long-lived immunity. Numerous studies have identified and characterized SARS-CoV-2-63 specific CD4+ T cells in severely ill as well as individuals recovered from mild COVID-19 64 (Grifoni et al., 2020 , Juno et al., 2020 , Le Bert et al., 2020 , Sekine et al., 2020 , Weiskopf et al., 65 2020 . The frequency of these cells has been positively associated with the levels of spike-66 specific antibodies in plasma (Grifoni et al., 2020) . Moreover, circulating T follicular helper 67 cells specific for the spike-protein were shown to correlate with the frequency of cognate 68 memory B cells (Juno et al., 2020) . Collectively, these findings confirm the dependence of B 69 cell responses on CD4+ T cells during COVID-19. Nevertheless, little is known about the 70 specificity and functions of CD4+ T cells that support the formation of long-lived spike-71 specific B cell memory in SARS-CoV-2-infected individuals. Here we analyzed the properties 72 of S1-specific memory B cells together with S-, N-, and M-specific CD4+ T cells responses in 73 two different disease settings; severe COVID-19 and recovery after mild infection. 74

Furthermore, we correlate CD4+ T cell functions, crucial for the development of B cells, with 75

the quantity and quality of B cell memory. 76 J o u r n a l P r e -p r o o f 3

Subjects recovered from a mild SARS-CoV-2 infection demonstrate lower frequency 78 but better quality of spike-specific memory B cells compared to severely ill 79 Current data indicate that antibody responses to SARS-CoV-2 infection decay more 80 rapidly in comparison to other viral diseases (Huang et al., 2020, Kellam and Barclay, 2020) . 81

In contrast, SARS-CoV-2-specific memory B cells appear to be more persistent and may 82 mediate longer immunity (Vaisman-Mentesh et al., 25.08.2020) . It is therefore important to 83

investigate memory B cells of SARS-CoV-2-infected individuals and elucidate the factors 84 pivotal for their generation. To address this we investigated memory B cell responses in 85 peripheral blood of three groups of individuals: those that recovered from mild to moderate 86 symptomatic COVID-19 (referred to as recovered individuals, n=19), individuals that were 87 hospitalized at the intensive care unit (ICU) due to severe COVID-19 (referred to as severely 88

ill individuals, n=13), and healthy (n=8) subjects. Demographic data regarding individuals 89 included in our study can be found in Supplemental Table 1 . In particular, we focused on the 90 B cells specific for the S1 subunit of the spike protein, which harbors the receptor-binding 91 site and might, therefore, be the primary target of neutralizing antibodies. We first 92 compared the frequency of S1-specific memory B cell responses and observed higher levels 93

in individuals with severe COVID-19 (0.076±0.047% of B cells) compared to recovered 94 individuals (0.023±0.014% of B cells) suggesting an augmented B cell response in severely ill 95 patients (p=0.0005) (Figure 1a ). Considering BCR isotype, IgA+ and IgM+ S1-specific memory 96 B cells were more frequent in severely ill individuals. The frequency of IgG+ S1-specific 97 memory B cells was not significantly different between the groups ( Figure 1b) . Interestingly, 98

IgG was the most frequent isotype among the S1-specific memory B cells of recovered 99

individuals, but not in individuals with severe COVID-19 and healthy individuals (Figure 1c ). 100

These findings suggest that individuals recovered from mild COVID-19 generally develop less 101 S1-specific memory B cells that, unlike those of severely ill individuals, predominantly 102 express IgG on their surface. 103 Furthermore, we observed that S1-specific memory B cells of healthy individuals, 104

which are most likely cross-reactive memory B cells, predominantly bind low amounts of the 105 S1-probe. Based on the binding capacity of these cells we defined a cutoff between the B cell 106 populations binding low and high amounts of the S1-protein (Figure 1d ). We then compared 107 the frequency of memory B cells binding high amounts of S1 protein between the severely ill 108 and recovered individuals. The data showed that, within the S1+ memory B cell population, 109 recovered individuals have more IgG+ but fewer IgA+ and IgM+ memory B cells binding high 110 amounts of the S1 protein ( Figure 1e ). This might be due to the differences in the BCR 111 isotype usage, since we observed that, in recovered individuals, memory B cell binding high 112 levels of S1 protein mostly bear IgG BCR. In contrast, all three isotypes were equally 113

represented among the cells of severely ill individuals ( Figure 1f ). Since IgG is generally 114 considered superior to IgA and IgM, this indicates that recovered individuals might have 115 functionally superior spike-specific memory B cells. 116

We also compared the avidity of BCR present on the surface of S1-specific memory B 117 cells. The avidity was assessed by normalizing the mean fluorescence intensity of bound S1-118 probe with the level of BCR expression as described previously [17] [18] [19] . While in the case of 119 J o u r n a l P r e -p r o o f 4 IgG and IgA we observed no differences between the severely ill and recovered group, the 120 avidity of IgM was significantly increased in the severely ill group (Figure 1g ). 121

Collectively, our findings suggest that severely ill SARS-CoV-2-infected individuals 122 generate higher levels of spike-specific memory B cells than individuals recovered from mild 123 COVID-19. However, S1-specific memory B cells of recovered individuals have a higher 124

proportion of IgG+ cells with a high binding capacity for the S1 protein. 125 SARS-CoV-2 membrane (M) protein evokes superior T cell response when compared to 126 Spike (S) and nucleocapsid (N) proteins.

The formation of an efficient antiviral B cell response largely depends on CD4+ T cell 128 help that is delivered in a form of surface signaling molecules and cytokines. demonstrating relatively low immunogenicity of the latter (Figure 2c ). 160 J o u r n a l P r e -p r o o f 5 We next analyzed the polyfunctional profile of SARS-CoV-2-specific CD4+ T cell 161 responses using the SPICE software (Roederer et al., 2011) . The majority of SARS-CoV-2-162 specific CD4+ T cells expressed only CD40L, followed by cells co-expressing CD40L and IFNγ 163 and those expressing exclusively IFNγ. IL-21 or IL-4/13 responses were less frequent. This 164 trend was observed within all subject groups and simulations. Importantly, stimulation of 165 infected individuals with M protein led to a more diverse functional profile with a higher 166

proportion of cells that do not respond solely with CD40L expression (Figure 2d ). 167

Taken together, our findings suggest that, similar to B cell response, the magnitude of 168 SARS-CoV-2-specific CD4+ T cells response increases with the severity of the disease. 169

Moreover, the response to M protein was higher in magnitude and more functionally diverse 170 as compared to S and N proteins. To determine the properties of memory CD4+ T cells governing the quantity and 174 quality of spike-specific memory B cells in individuals recovered from mild COVID-19, we 175 compared frequencies of S-, N-and M-specific memory CD4+ T cells exerting different 176 effector functions with parameters defining quality and quantity of the B cell response 177

including; frequencies of S1-specific bulk, class-switched, IgG+, IgA+, and unswitched 178 memory B cells along with the BCR avidity of the latter three subsets. Surprisingly, our 179 analysis showed an overall negative relationship between the robustness of S1-specific B cell 180 response and the functions of S-specific CD4+ T cells. The strongest negative association 181

showed cells expressing CD40L and IFNγ that significantly correlated with the frequency of 182 S1+IgA+ memory B cells (r=-0.51, p=0.031) and avidity of S1-specific IgG-isotype BCR (r=-183 0.57, p=0.014), respectively. A similar negative trend was observed for most of the functions 184 of N-specific CD4+ T cells, although none of the correlations showed statistical significance. 185

Conversely, CD4+ T cells recognizing the M protein were positively associated with the 186 quantity and quality of S1-specific memory B cells. In particular, IL-21-secreting cells were 187 significantly correlated with the frequency of bulk (r=0.56, p=0.015) as well as IgG (r=0.52, 188 p=0.027) and IgA (r=0.49, p=0.040) class-switched S1+ memory B cells. Furthermore, this 189 subset was associated with high avidity of IgG-isotype BCR on S1+ memory B cells (r=0.65, 190 p=0.0032), suggesting its prominent role in affinity maturation ( Figure 3a ). To fully 191 understand the functional profile of memory CD4+ T cells that might be involved in the 192 formation of SARS-CoV-2 spike-specific B cell response, we correlated the frequencies of 193 polyfunctional CD4+ T cell subsets expressing different combinations of CD40L, IFNγ, 194 and IL-21 with the B cell parameters. In concordance with the rest of the data, the strongest 195 association showed memory CD4+ T cells specific for the M protein that either expressed 21 alone or in a combination with CD40L and IFNγ (Supplemental figure 1a) . 197

We next compared the frequency of SARS-CoV-2-specific CD4+ T cells and plasma 198 levels of S1-specific IgA and IgG along with neutralization capacity. While we did not observe Taken together, we demonstrated that the frequency of M-specific memory CD4+ T 207 cells expressing IL-21 alone or in combination with IFNγ and CD40L correlates with the 208 frequency and BCR avidity of S1-specific B cell memory. COVID-19 showed the same memory subset composition as those of healthy individuals, the 219 composition of IgG+ S1-specific cells was significantly altered. In particular, the proportion of 220 RM was decreased among IgG+ S1-specific cells (35±13%) when compared to bulk IgG+ 221 memory B cells of either healthy (53±6%) or recovered individuals (52±11%) (p=0.0002, 222

p<0.0001 respectively). Furthermore, the data revealed a significant increase in the 223

proportion of TLM comparing IgG+ S1-specific cells (21±14%) with bulk IgG+ memory B cells 224 of healthy (9±4%) and recovered individuals (9±4%) (p=0.019, p=0.0003 respectively) ( Figure  225 4a). These findings suggest an increased proportion of SARS-CoV-2-specific IgG+ memory B 226 cells with activated and exhausted phenotype. 227

Given the possible role of CD4+ T cell helper functions in sustaining S1-specific 228 memory B cells, we next assessed whether they also have an impact on memory phenotype. 229

Indeed, we observed a significant positive association between the S-specific CD4+ T cells 230 expressing CD40L (r=0.61, p=0.0067) or IFNγ (r=0.47, p=0.047) and the proportion of RM. A 231 similar trend was observed for the cells expressing CD40L in response to stimulation with the 232 M peptide pool (r=0.45, p=0.063) ( Figure 4b ). Considering the co-expression of molecules 233 providing help to B cells, we observed that numerous subsets specific for S and M proteins 234 are associated with the phenotype of memory B cells. In general, the frequency of IM was 235 negatively correlated, while the frequencies of AM and RM were positively associated with 236 subsets expressing different combinations of the CD40L, IFNγ, IL4/13, and IL-21 237 (Supplemental figure 1c) . 238

Collectively, this data suggests a decreased proportion of long-lived highly functional 239 RM phenotype among the IgG+ S1-specific memory B cells of recovered individuals. While 240 the factors driving skewing of the S1-specific memory B cell compartment remain unknown, 241

S-and M-specific CD4+ T cells expressing different combinations of CD40L, IFNγ, IL4/13, and 242 IL-21 were associated with a low proportion of IM in favor of the AM and RM. 243 7 CD40L-expressing CD4+ T cells are associated with affinity maturation of spike-specific 244 memory B cells in severely ill individuals

As we elucidated the association between the SARS-CoV-2-specific CD4+ T cell and B 246 cell memory in recovered individuals, we next evaluated this relationship in severely ill 247

individuals. Comparing the same CD4+ T cell functions and B cell parameters, we observed a 248 significant positive association between the frequency of CD40L-expressing CD4+ T cells and 249 the avidity of IgG on the surface of S1+ memory B cells. Interestingly, this was the case for S-250 (r=0.83, p=0.0047), N-(r=0.77, p=0.013) and M-specific CD4+ T cells (r=0.65, p=0.049). 251

Moreover, we found a positive correlation between the proportion of IL-21-secreting CD4+ T 252 cells responding to stimulation with M protein and the frequency of S1-specific IgM+ 253 memory B cells (r=0.66, p=0.043) ( Figure 5a ). Importantly, the latter had a high binding 254 capacity for the S1 protein during severe COVID-19. We also investigated the CD4+ T cell 255 subsets co-expressing different combinations of CD40L, IFNγ, IL-4/13, and IL-21 and their 256 possible role in providing help to spike-specific B cells. Notably, memory CD4+ T cells 257 expressing only CD40L correlated with the avidity of IgG on the surface of S1-specific 258 memory B cells regardless of their specificity. Moreover, the subset co-expressing CD40L, 259

IFNγ, and IL-21, and the subsets co-expressing CD40L and IL-21 positively correlated with the 260 avidity of IgG BCR. Both subsets were specific for the S protein (Supplemental figure 2a) . Taken together, we demonstrated that CD40L-expressing CD4+ T cells are the best 271 correlate of the high-avidity IgG found on S1-specific memory B cells. Importantly, the 272 plasma neutralization capacity of severely ill individuals was positively associated with 273 CD40L, IFNγ, IL-21 production in CD4+ T cells. Similarly, as for recovered individuals, we assessed the subset composition of IgG+ 277 memory B cells in severely ill individuals. Strikingly, we found a severely altered phenotype 278 of both, bulk IgG+ memory B cells as well as S1-specific IgG+ memory B cells. Comparing the 279 bulk IgG+ memory B cells, we observed a significant increase of AM (15±5%) in severely ill 280 when compared to healthy (7±3%) individuals (p=0.0036). Moreover, the proportion of TLM 281 was higher in severely ill (16±8%) than healthy (9±4%) subjects (p=0.0073), pointing at a 282 severe immune activation ongoing in these patients. In the case of S1-specific IgG+ memory 283 B cells of severely ill individuals, however, the same trend was observed but the differences 284 J o u r n a l P r e -p r o o f 8 were not significant due to the large variability between individuals (Figure 6a ). The high 285 variance can be explained by the low number of detected S1-specific cells in some cases. 286

Comparing the prevalence of memory B cell subsets between the severely ill and 287 recovered individuals, we observed significant differences at the level of bulk IgG+ memory B 288 cells. In particular, the proportion of AM (p<0.0001) and TLM (p=0.0013) was significantly 289 higher in severely ill, while the IM (p=0.029) subset was more frequent in recovered 290

individuals. For the S1-specific IgG+ memory B cells, we did not observe any significant 291 differences between the groups with exception of IM (p=0.016) frequency that was higher in 292 recovered individuals (Figure 6b ). 293

We next evaluated the impact of SARS-CoV-2-specific CD4+ T cells on the memory 294 phenotype of IgG+ S1+ memory B cells in severely ill individuals. We found that the 295 proportion of RM phenotype inversely correlated with the frequencies of CD40L-expressing 296 CD4+ T cells specific for S (r=-0. cell activation and exhaustion. A positive trend was also observed between the frequencies 306 of TLM and IFNγ-secreting CD4+ T cells specific for the N protein (r=0.62, p=0.063) ( Figure  307 6c). Considering the co-expression of molecules mediating help to B cells, the proportion of 308 TLM was strongly associated with the following memory CD4+ T cells: subset co-expressing 309 CD40L, IFNγ, and IL-21, subset expressing CD40L and IFNγ, subset expressing CD40L and IL-310 21, and subset expressing only IFNγ. The same polyfunctional CD4+ T cells, negatively 311 correlated with the proportion of RM phenotype. These correlations were the most 312 profound in the case of memory CD4+ T cells specific for the M protein although the same 313 trend was also observed for S and N proteins. 314

Collectively, these findings suggest skewing of the memory B cell compartment in 315 severely ill SARS-CoV-2-infected individuals towards activated and exhausted phenotypes. 316

This activation can be potentially explained by high frequencies of SARS-CoV-2-specific CD4+ 317

T cells expressing stimulatory proteins such as CD40L, IFNγ, and IL-21. 318

Seasonal coronavirus infections usually evoke short-lived immunological memory 320 responses and reinfection can therefore reoccur as soon as six months after initial infection 321 (Kissler et al., 2020 , Edridge et al., 2020 . The same may be true for infection with the novel 322 SARS-CoV-2 since recent studies suggested accelerated waning of antibody responses 323

following COVID-19 (Ibarrondo et al., 2020 , Seow et al., 2020 . Conversely, SARS-CoV-2-324 specific memory B cell levels seem to remain constant at least during the first five months 325

following the onset of the disease (Vaisman-Mentesh et al., 25.08.2020). This makes 326 9 memory B cells of great interest since they could be the critical component of long-lived 327 immunity against SARS-CoV-2 infection. In our present study, we investigated the possible 328

impact of CD4+ T cell functions on the formation of spike-specific B cell memory in 329 individuals recovered from mild SARS-CoV-2 infection and severely ill individuals. We show 330 that in recovered individuals IL-21 expression is the major function associated with a robust 331 B cell memory. Conversely, in severely ill individuals CD40L expression was positively 332 correlated with the avidity of IgG but at the same time contributed to activation and 333 exhaustion of the memory B cells. 334

For long-term protection from SARS-CoV-2 infection, virus-specific memory B cells 335 may be of greater importance than the antibodies whose levels decline rapidly after 336

infection. In particular memory B cells targeting receptor-binding spike protein might be a 337 decisive factor for long-term protection. Several studies have detected spike-specific 338 memory B cells in recovered individuals (Kreer et al., 2020 , Juno et al., 2020 , Vaisman-339 Mentesh et al., 25.08.2020 . In line with their findings, we demonstrated the presence of S1+ 340 memory B cells in individuals recovered from a mild COVID-19 as well as severely ill ICU 341

patients. While severely ill individuals developed significantly higher levels of S1-specific 342 memory B cells, recovered individuals showed a higher proportion of memory B cells with 343

IgG BCR that are generally considered superior to IgM or IgA. Moreover, S1-specific memory 344 B cells of recovered individuals harbored a higher proportion of IgG+ cells able to bind high 345 amounts of S1 protein. In the case of severely ill individuals, however, there was a higher 346

proportion of IgA+ and IgM+ memory B cells with increased S1-binding capacity. Overall, 347 these findings suggest that severely ill individuals develop higher levels of spike-specific 348 memory B cells than individuals recovered from mild COVID-19 but lack the class-switching 349

to IgG. It is, however, important to consider that differential decay of the specific memory B 350 cells over time could contribute to the observed differences. The extent of this contribution, 351 however, might not be significant since it has been shown that SARS-CoV-2-spike-specific 352 memory B cells remain stable at least for the 6 months post-recovery (Vaisman-Mentesh et  353 al., 25.08.2020). 354

One of the main factors driving B cell and humoral responses against viral proteins is 355 CD4+ T cell help. Recent reports confirmed the presence of virus-specific CD4+ T cells in 356 SARS-CoV-2-infected individuals (Grifoni et al., 2020 , Juno et al., 2020 , Le Bert et al., 2020 , 357 Weiskopf et al., 2020 , Oja et al., 2020 . While cells reactive against the entire proteome have 358 been identified, the immunodominant regions are those encoding for the S, N, and M 359 proteins (Grifoni et al., 2020 , Oja et al., 2020 . We, next investigated functions of S-, N-, and 360

M-specific CD4+ T cells that are important for B cell help. From the currently available 361 literature, it is not clear whether the magnitude of SARS-CoV-2-specific CD4+ T cell response 362 is higher in severely ill individuals or those recovered from the mild disease (Oja et al., 2020 , 363 Sekine et al., 2020 . Similar to a previous study (Sekine et al., 2020) we have demonstrated 364 the highest magnitude of SARS-CoV-2-specific CD4+ T cells was observed in severely ill 365

individuals with an exception of IL4/13-secreting cells that were more frequent in recovered 366

individuals. The frequency of CD4+ T cell response also largely depended on their specificity. 367

In most cases, the highest response was specific for the M protein as compared to S and N. 368

The same trend has been previously observed for the SARS-CoV-2-specific IFNγ response 369 10 (Sekine et al., 2020) . Moreover, the functional composition of M-specific CD4+ T cells 370

showed to be more diverse. 371

To understand the importance of SARS-CoV-2-specific memory CD4+ T cells in the 372 formation of S1-specific B cell memory, we compared the magnitude of T cell functions and 373 B cell parameters describing the quantity and quality of the response. We demonstrated that 374

in recovered individuals IL-21-secreting CD4+ T cells specific for the M but not N or S protein 375 are strongly associated with the generation of class-switched S1+ memory B cells and 376

increase the affinity of their BCR. In severely ill individuals, however, the affinity maturation 377 of S1+ memory B cells was associated with CD40L-expressing CD4+ T cells specific for any of 378 the three proteins. Furthermore, we investigated the influence of CD4+ T cell functions on 379 the development of S1-specific humoral response. We observed positive correlations 380 between the M-specific polyfunctional CD4+ T cells and plasma IgG and IgA levels. Similarly, 381

previous studies have shown a positive correlation between the magnitudes of CD4+ T cells 382

and plasma IgG and IgA specific for the virus in recovered individuals (Grifoni et al., 2020 , Oja 383 et al., 2020 . In severely ill patients the subset associated with high avidity of BCR also 384 positively correlated with the neutralization capacity of respective plasma, suggesting 385 profound importance of CD40L-expressing CD4+ T cells in severe COVID-19. The plasma 386 neutralization capacity of severely ill individuals was also positively associated with IFNγ, IL-387 21 production in CD4+ T cells. 388

An important indicator of quality and durability of the memory B cells are their 389 phenotypic traits dividing them into four memory subsets: RM, AM, IM, and TLM. In the 390 peripheral blood of healthy individuals RM is the prevalent subset, however, during several 391 viral infections its prevalence decreases in favor of atypical subsets like AM and TLM 392 (Oliviero et al., 2015 , Burton et al., 2018 , Kardava et al., 2014 . In particular, the TLM subset 393

showed aberrant properties in settings of HIV infection, like an increased expression of 394 exhaustion and activation markers and a decreased rate of SHM (Kardava et al., 2014) . 395

Similar to the previous study (Oliviero et al., 2020) , we found that the individuals recovered 396 from mild COVID-19 have the same composition of bulk memory B cell compartment as 397 healthy donors. The subset composition of S1-specific memory B cells however was 398 significantly altered. We observed a decrease in the frequency of RM and an expansion of 399 the TLM subset. The memory subset composition of the S1-specific B cells was potentially 400 influenced by S-and M-specific CD4+ T cells expressing different combinations of CD40L, 401

IFNγ, and IL-21. In severely ill individuals the skewing of the B cell compartment was more 402 severe and could be observed for the bulk memory B cell population. In particular, the 403 frequencies of AM and TLM subsets were significantly increased compared to healthy and 404 recovered individuals, while the frequency of IM decreased. These changes were even more 405 profound in the S1-specific memory B cell population but were overall not significant due to 406 the high variability among the individuals. The reason for this variability was the poor 407 condition of some severely ill individuals whose PBMCs consequently had unusually low 408

viability. In these cases, we were not able to detect many viable IgG+ S1-specific B cells 409 causing a high deviation in the memory subset distribution. Of note, the frequency of CD4+ T 410 cells expressing CD40L, IFNγ, and IL-21 positively correlated with S1-specific TLM and 411 inversely with RM, suggesting that high levels of functional CD4+ T cells lead to aberrant 412 activation and exhaustion of memory B cells in severely ill individuals. 413

Taken together our data provide a detailed insight into the composition and 414

formation of S1-specific memory B cells in two distinct courses of COVID-19; severe disease 415 and mild cold-like infection. We show that in individuals recovered from mild infection IL-21 416 secretion is the primary CD4+ T cell function associated with the quantity and quality of S1-417 specific memory B cells. In severely ill, however, this role is taken over by the CD40L-418 expressing CD4+ T cells. Intriguingly, CD4+ T cells specific for the M protein better correlated 419

with the spike-specific B cell response compared to those specific for S and N proteins. We 420 believe that our findings provide valuable information for the design of a SARS-CoV-2 421

vaccine that would provide long-term immune protection. Shown is the mean frequency of memory B cells binding recombinant S1 protein as a 444

percentage of all B cells. Contributions of cells positive for IgM, IgA, and IgG are shown as 445 stacked columns. b) Comparison of S1-specific memory B cell levels between the healthy, 446 recovered, and severely ill individuals. c) Comparison of BCR-isotype prevalence among the 447 S1-specific memory B cells in three different groups of individuals. d) Representative flow 448 cytometry plots demonstrating the capacity of memory B cells to bind the S1 protein. e) 449

Comparison of S1-specific memory B cell frequencies binding high amounts of the S1 protein 450 12 between the recovered, and severely ill individuals. f) Comparison of BCR-isotype prevalence 451 among the S1-specific memory B cells binding high amounts of the S1 protein. g) Avidity of 452 the IgG+, IgA+, or IgM+ on the surface of S1-specific memory B cells. Shown are comparisons 453 for all three groups of individuals. The number of independent experiments represented in 454 the above graphs is n=8 for healthy, n=11 for severely ill, and n=19 for the recovered group. 455

Data are presented as mean ± SD. Differences between the groups were assessed using the 456 Mann-Whitney test or Wilcoxon test for matched data. 457 represented in the above graphs is n=8 for healthy, n=13 for severely ill, and n=18 for the 469 recovered group. Data are presented as mean ± SD. Differences between the groups were 470 assessed using the Mann-Whitney test or Wilcoxon test for matched data. 471 between the CD4+ T cell functions and parameters determining quantity and quality of S1-474 specific memory B cell response. Each heat-map shows CD4+ T cell response specific for one 475 of the three proteins. Cells are color-coded concerning spearman's correlation coefficient. 476

Significant correlations are marked by asterisks. b) Heat-maps depicting correlations 477 between the magnitude of CD4+ T cell helper functions and determinants of humoral 478 response including levels of S1-specific IgG, IgA, and neutralization capacity. Each heat-map 479

shows CD4+ T cell response specific for one of the three proteins. The number of 480 independent experiments represented in the above graphs is n=18. See also supplemental 481 figure 1. 482

proportions of memory subsets within the bulk and S1-specific memory B cell populations as 484 compared to the healthy control. The number of independent experiments is n=8 for the 485 healthy, and n=18 for the recovered group. Data are presented as mean ± SD. Differences 486 between the groups were assessed using the Mann-Whitney test or Wilcoxon test for 487 matched data. b) Correlative relationships show the impact of CD4+ T cell functions on the 488 memory phenotype of S1+ memory B cells. Each heat-map shows CD4+ T cell response 489 specific for one of the three proteins. Cells are color-coded concerning spearman's 490 correlation coefficient. Significant correlations are marked by asterisks. The number of 491 independent experiments is n=18. 492

between the CD4+ T cell functions and parameters determining quantity and quality of S1-495 specific memory B cell response. Each heat-map shows CD4+ T cell response specific for one 496 of the three proteins. Cells are color-coded concerning spearman's correlation coefficient. 497

Significant correlations are marked by asterisks. b) Heat-maps illustrate correlations 498

between the magnitude of CD4+ T cell helper functions and factors describing humoral 499 response (levels of S1-specific IgG, IgA, and neutralization capacity). Each heat-map shows 500 CD4+ T cell response specific for one of the three proteins. The number of independent 501 experiments represented in the above graphs is n=11. See also supplemental figure 2. 502

proportions of memory subsets within bulk and S1-specific memory B cell populations in 504 comparison with the healthy control. b) Compared are the frequencies of memory B cell 505 subsets between the severely ill and recovered individuals for bulk IgG+ and S1+ IgG+ 506 memory B cell populations. The number of independent experiments is n=8 for healthy, 507 n=11 for the severely ill, and n=18 for the recovered group. Data are presented as mean ± 508 SD. Differences between the groups were assessed using the Mann-Whitney test or 509

Wilcoxon test for matched data. c) Correlation maps show associations between CD4+ T cell 510

functions and memory phenotype of S1+ memory B cells. Each map shows the CD4+ T cell 511 response specific for one of the three proteins. Cells are color-coded concerning spearman's 512 correlation coefficient. Significant correlations are marked by asterisks. The number of 513 independent experiments is n=11. 514

Key Resources Table   516 Resource Availability

Lead contact 518 Further information and requests for resources and reagents should be directed to and will 519 be fulfilled by the lead contact, Hendrik Streeck (hendrik.streeck@ukbonn.de). 520

This study did not generate new unique reagents. 522

The published article includes all datasets generated during this study. Raw data are 524 available from the lead contact upon request. 525

Study participants 527

Twenty-seven individuals were selected from a cross-sectional study cohort (Streeck 528 et al., 2020) . The study was approved by the Ethics Committee of the Medical Faculty of the 529

University of Bonn and informed consent was obtained from all subjects. Nineteen of the 530 twenty-seven enrolled individuals were seropositive for the SARS-CoV-2. These individuals 531 14 presumably got infected during the super-spreading event while participating in the carnival 532 festivities on 15. February 2020. The samples were taken between the 7. and 9. April 2020 so 533 52-54 days post-infection. All the individuals were asymptomatic at the time of sampling and 534

reported only mild flu-like symptoms (fever, coughing, loss of taste, loss of smell, or 535 dyspnea) for the time of illness. Eight participants were healthy individuals with no 536 detectable SARS-CoV-2-specific IgA and IgG. Moreover, a cohort of severely ill patients 537 (n=13) who had been hospitalized with acute respiratory distress syndrome (ARDS) and 538 supported with mechanical ventilation were enrolled. At the time of sampling, all severely ill 539 patients were treated at the intensive care units of the Community Hospital Heinsberg or 540

University Hospital Bonn in Germany. The date of onset and other details about the course 541 of the disease before their hospitalization is not known for these individuals. Further details 542

regarding the study participants are available in Supplemental table 1. 543

Vero E6 cells (VERO C1008, ATCC) were maintained in Dulbecco's modified Eagle's medium 545

(DMEM) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS), and 546 100 U/mL penicillin and 100 μg/mL streptomycin. Cells were cultured in a humidified CO 2 547

incubator at 37°C. 548

549

Cryopreserved PBMC were thawed and rested overnight at 37°C. Next, B cells were 551 isolated, after counting and PBS washing steps, using a magnetic B cell isolation kit following 552 the manufacturer's protocol (Human CD19 MultiSort Kit, Miltenyi Biotec). In brief, cells were 553 resuspended in MACS buffer (PBS supplemented with 0.5% BSA, and 2nM EDTA) and labeled 554 with anti-CD19 antibody attached to magnetic beads. The cell suspension was then passed 555 through a positive selection column resulting in immobilization of labeled CD19+ cells. The 556 flow-through was collected for the assessment of CD4+ T cell responses. The immobilized 557 fraction was washed out of the column and magnetic beads were enzymatically released 558 from the cells. Isolated bead-free CD19+ cells were used for further experiments. 559

Magnetically isolated B cells were resuspended in FACS buffer (PBS supplemented  561 with 2% FCS, 0.05% NaN 3, and 2mM EDTA) and incubated with the fluorescently labeled 562 recombinant SARS-CoV-2 S1 protein (Biotinylated SARS-CoV-2 (COVID-19) S1 protein, 563

Acrobiolabs). To minimize the unspecific binding of the probe, S1 protein was conjugated to 564 two different streptavidin-fluorochrome conjugates, streptavidin-PE and streptavidin-APC, in 565 an equimolar ratio. After 15 min at 4°C anti-IgG-BV421 antibody (clone G18-145) was added 566

to the cell suspension and the incubation was continued for another 15 min. Following the 567 binding of S1 probes, cells were washed with PBS and stained for viability (ZombieAqua, 568 Biolegend in laser intensity were monitored every day before the experiment and were compensated 577 using fluorescent beads (Rainbow beads, Biolegend). The avidity of the BCR for S1 protein 578

was assessed based on the MFI of fluorescent S1-probe normalized with the MFI of the 579 corresponding BCR isotype. The data were analyzed with the FlowJo Software version 10.0.7 580 (TreeStar). 581

Following magnetic isolation of B cells the remaining PBMC were allowed to rest 583 overnight in R10 media (RPMI-1640 supplemented with 10% heat-inactivated fetal calf 584 serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 10 mM HEPES) 585

at 37°C Briefly, plasma samples were thawed and diluted 1:101 in sample buffer. Subsequently, 616 diluted samples were pipetted into test tubes pre-covered with SARS-CoV-2 spike protein 617 and incubated 60 min at 37°C. Samples were washed three times and subsequently 618 incubated with peroxidase-conjugated anti-IgA or anti-IgG antibody. After the incubation (30 619 min at 37°C) chromogenic substrate was added and samples were incubated for 30 min at 620 room temperature. Finally, the reaction was stopped by the addition of the stop solution, 621

and absorbance was measured on EUROIMMUN Analyzer I platform. A sample was 622 considered positive if the ratio between the absorbances of the sample and calibrator was 623 above 1.1. 624

To determine the SARS-CoV-2 neutralization capacity of patient plasma a plaque 625 reduction neutralization test was performed as previously described (Streeck et al., 2020) . 626

Briefly, plasma samples were thawed, heat-inactivated for 30 min at 56 °C, and centrifuged 627

for 5 min at 5000 rpm. The supernatant was carefully collected and serially two-fold diluted 628 starting with 1: 2 up to 1:16384. Subsequently, 120 μl of each plasma dilution was mixed 629

with 80 plaque-forming units (PFU) of SARS-CoV-2 in 120 μl OptiPRO SFM (Gibco) cell culture 630 medium. After 1h incubation at 37°C, 200 μl of each dilution mixture were added to wells of 631 a 24 well plate previously seeded with 1.5x10 5 Vero E6 cells/well. Following 1h incubation at 632 37°C, the inoculum was removed and cells were overlaid with a 1:1 mixture of 1.5 % (w/v) 633 carboxymethylcellulose (Sigma-Aldrich) in 2xMEM (Pan Biotech) supplemented with 4% FBS. 634

After incubation at 37°C and 5% CO 2 for three days, the overlay was removed and the 24 635 well plates were fixed using a 6% formaldehyde solution and stained with 1% crystal violet in 636 20% ethanol revealing the formation of plaques. 637

Statistical analysis and graphing of the data were performed using GraphPad Prism 639 and SPICE software. Data are presented as mean ± SD for biological replicates. Differences 640 between the groups were assessed using the Mann-Whitney test or Wilcoxon test for 641 matched data. The strength of correlations was evaluated by Spearman's test. Correlated 642 parameters are interdependent and were preselected based on our hypothesis and available 643 knowledge on the interplay between B and T cells in viral infections. Therefore, the p-values 644

were not adjusted for multiple comparisons. However, we acknowledge that, based on the 645 number of comparisons made, some of these correlations might occur by chance. Statistical 646 significance is indicated by the following annotations: *p<0.05, **p<0.01, ***p<0.001, 647 ****p<0.0001. Statistical tests used to determine the degree of significance and the number 648 of biological replicates shown in each graph can be found in figure legends. 649 

WHO Coronavirus Disease (COVID-19) Dashboard [Online

Circulating and intrahepatic antiviral B cells are 655 defective in hepatitis B

Seasonal coronavirus 659 protective immunity is short-lasting

Targets of T Cell Responses to SARS-CoV-664

Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

A systematic review of antibody 670 mediated immunity to coronaviruses: kinetics, correlates of protection, and 671 association with severity

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Humoral and circulating follicular helper T cell 680 responses in recovered patients with COVID-19

Abnormal B cell memory subsets dominate HIV-specific responses 685 in infected individuals

The dynamics of humoral immune responses following 687 SARS-CoV-2 infection and the potential for reinfection

Projecting 689 the transmission dynamics of SARS-CoV-2 through the postpandemic period

Longitudinal Isolation of 696 Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected 702 controls

Divergent SARS-CoV-2-specific T-and B-cell responses in 707 severe but not mild COVID-19 patients

Skewed B cells in chronic hepatitis C virus 710 infection maintain their ability to respond to virus-induced activation

Expansion of atypical memory B cells is a 714 prominent feature of COVID-19

SPICE: exploration and analysis of post-716 cytometric complex multivariate datasets

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild 724 COVID-19

Longitudinal observation and decline of 733 neutralizing antibody responses in the three months following SARS-CoV-2 infection 734 in humans

Infection fatality rate of SARS-CoV2 in a 740 super-spreading event in Germany

SARS-CoV-2 specific memory B cells frequency in 743 recovered patient remains stable while antibodies decay over time. medRxiv

Phenotype and 748 kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory 749 distress syndrome

SARS-CoV-2 infection induces sustained humoral immune 754 responses in convalescent patients following symptomatic COVID-19